Omega Therapeutics Inc (OMGA)
1.96
-0.21
(-9.68%)
USD |
NASDAQ |
May 10, 16:00
1.955
0.00 (0.00%)
After-Hours: 20:00
Omega Therapeutics Total Assets (Quarterly): 183.68M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 183.68M |
| December 31, 2023 | 204.37M |
| September 30, 2023 | 217.81M |
| June 30, 2023 | 229.02M |
| March 31, 2023 | 156.32M |
| December 31, 2022 | 146.00M |
| September 30, 2022 | 170.06M |
| Date | Value |
|---|---|
| June 30, 2022 | 193.05M |
| March 31, 2022 | 217.30M |
| December 31, 2021 | 233.33M |
| September 30, 2021 | 243.27M |
| June 30, 2021 | 130.05M |
| March 31, 2021 | 144.07M |
| December 31, 2020 | 28.08M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
28.08M
Minimum
Dec 2020
243.27M
Maximum
Sep 2021
178.31M
Average
188.36M
Median
Total Assets (Quarterly) Benchmarks
| Fate Therapeutics Inc | 506.22M |
| Ocular Therapeutix Inc | 538.95M |
| AnaptysBio Inc | 452.39M |
| Amneal Pharmaceuticals Inc | 3.456B |
| Stoke Therapeutics Inc | 205.18M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 142.33M |
| Shareholders Equity (Quarterly) | 41.35M |
| Debt to Equity Ratio | 0.4328 |
| Current Ratio | 2.872 |
| Net Debt Paydown Yield | 0.20% |